MedPath

Age determination of bloodstains on the basis of a shift of the absorption spectrum

Conditions
Healthy Volunteer
Registration Number
DRKS00010621
Lead Sponsor
niversitätsklinikum Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
2
Inclusion Criteria

Healthy volunteer

Exclusion Criteria

o Member of high-risk-groups of hepatitis B-, C- or HIV-infection (Prostitutes, i.v. drug abuse, homosexuals)
o chronical diseases of the heart (e.g. insufficincy, infarction)
o chronical diseases of the lung (chronical bronchitis, emphysema)
o stroke/cerebral apoplexy
o epilepsy
o diseases of the bone marrow
o Protozoonose: Babesiose, Trypanosomiasis (Chagas-desease), Leishmaniosis
o Bucellose, Rickettsiose
o confirmation of hepatitis C- or HIV-infection
o acute Malaria-disease
o allergic asthma bronchiale
o malignant neoplasias
o chronical diseases of liver and kidney
o Diabetes Mellitus (insulindepending)
o Alcoholism
o medication addiction
o Stay in Britain or Northern Ireland > 6 Months between 1980 and 1996

2. restricted criteria of exclusion
o Hb-value: women =125 g/l, men =135 g/l
o thrombozytopenia < 120.000/µl
o deviation of bloodpressure: systolic <100mmHg, >180mmHg; diastolic >100mmHg
o puls: frequency >100/Minute
o every kind of fever in the last 4 weeks
o vaccination with live vaccine in the last 4 weeks, vaccination with toxoid vaccine in the last 2 days
o extensive surgery in the lst 6 months
o stay in endemic regions of malaria without any symptoms during or after the stay in the last 6 months
o pregnancy
o delivery in the last 6 months and lactation
o fever
o alcoholosation
o taking of medication:
• taking of aggregation inhibitors of thrombocytes or rheumamedication (Aspirin, Paracetamol, Ibuprofen) in the last 8 - 10 days
• taking of anticoagulants: marcumar in the last 8 weeks oder heparine in the last week
• taking of steroides in the last 4 weeks

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aim of the study is to determine the age of a bloodstain by measuring its absorption spectrum. For this, bloodstains of diffente ages are measured via spectrophotometer. The results are correlated with the age.
Secondary Outcome Measures
NameTimeMethod
The method shall be validated and established for routine work. It shall be used regularly in forensic work.
© Copyright 2025. All Rights Reserved by MedPath